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This report documents the characterization of a novel mouse oocyte protein which was originally identified by microsequence analysis of
a 67.8 kDa protein spot (pI 5.7) on a Coomassie-stained two-dimensional (2D) gel of murine egg proteins. Tandem mass spectroscopic
analysis of the peptides obtained from the cored protein yielded sequences that appeared to match only ovary, egg, and preimplantation
embryo cDNAs. We then cloned the novel gene by RACE-PCR, and analysis of the deduced cDNA sequence found that this maternal
product was ¨56% identical to human cytosolic phospholipase A2g (cPLA2g). Based on this sequence homology, we named the molecule
mouse cytosolic phospholipase A2g (cPLA2g). As with human cPLA2g, mouse cPLA2g contains a lipase consensus sequence and lacks the
calcium binding domain that is found in other PLA2 proteins. However, mouse cPLA2g is different from human cPLA2g in that mouse
cPLA2g expression is restricted to the ovary and that the protein does not contain the myristoylation and prenylation lipid-anchoring motifs
that are present in human cPLA2g. Within oocytes, mouse cPLA2g localizes mainly to the oocyte cortex and to the nucleoplasm.
Interestingly, during germinal vesicle breakdown, mouse cPLA2g aggregates dynamically relocate from the oocyte cortex to the nuclear
envelope, suggesting a possible role for this putative egg-restricted phospholipase A2g in membrane remodeling. Furthermore, mouse
cPLA2g protein continues to be expressed in the embryo until the 4–8-cell stage of development, suggesting that mouse cPLA2g may
function as a previously uncharacterized maternal effect gene.
D 2005 Elsevier Inc. All rights reserved.Keywords: cPLA2g; Maturation; Fertilization; PreimplantationIntroduction
Oocyte maturation, fertilization, and preimplantation
development are facilitated by maternal gene products
which accumulate in the oocyte during its growth (Latham
and Schultz, 2001). In an effort to further elucidate the
molecular identities of these poorly characterized molecules,
we have cloned and characterized a subset of genes from the
mouse oocyte proteome that encode highly abundant and0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.03.018
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E-mail address: scc2003@med.cornell.edu (S. Coonrod).oocyte-restricted proteins. Bioinformatic analysis of one
such gene product identified a novel egg protein, which we
named mouse cytosolic phospholipase A2g (cPLA2g) based
on its ¨56% identity to the previously characterized human
cPLA2g enzyme (Underwood et al., 1998). Phospholipase
A2 enzymes catalyze the hydrolysis of membrane glycer-
ophospholipids at the sn-2 position producing free fatty
acids and lysophospholipids (Brown et al., 2003). If
arachidonic acid is the esterified fatty acid, then downstream
metabolic enzymes, such as cyclooxygenases, convert this
fatty acid to various bioactive lipophilic compounds called
eicosanoids, which include prostaglandins (PGs) and
leukotrienes (LTs) (Lucas and Dennis, 2004). Primarily,82 (2005) 374 – 384
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identified and cloned in mammals: calcium-independent
cytosolic phospholipase A2 (iPLA2), secretory phospholi-
pase A2 (sPLA2), and cytosolic phospholipase A2 (cPLA2)
(Kudo and Murakami, 2002). The Ca2+ independent PLA2
(iPLA2) family contains two enzymes, VIA (iPLA2h) and
VIB (iPLA2g), which may play a major role in phospho-
lipid remodeling (Akiba and Sato, 2004). The secretory
PLA2 family consists of low-molecular weight Ca2+-
dependent secretory enzymes that have been implicated in
a number of biological processes, such as regulation of
eicosanoid production, inflammation, and host defense
(Kudo and Murakami, 2002). The cytosolic phospolipase
A2 (cPLA2) family, known as Group IV according to the
new nomenclature, consists of three isozymes, IVA
(cPLAa), IVB (cPLAh), and IVC (cPLAg), with molecular
masses of 85, 110, and 60 kDa respectively (Kudo and
Murakami, 2002). The most studied member of this group is
cPLAa, which contains two domains, a calcium-dependent
lipid domain (CaLB) and a catalytic domain, but lacks any
detectable sequence homology with the secreted forms of
PLA2 (Clark et al., 1991). cPLA2g, the least studied
member of this group, shows calcium-independent catalytic
activity and is constitutively associated with the lipid bilayer
via a prenylation moiety located at the C-terminus. This
prenylation site is critical for membrane localization and
thus for cPLA2g function (Murakami et al., 2003; Under-
wood et al., 1998).
While there is considerable evidence in the literature
suggesting that PLA2s are important for several stages of
early embryonic development (Carnero and Lacal, 1993;
Farber et al., 1999; Riffo and Parraga, 1997), the molecular
identities of these phospholipases have not been previously
documented. Here, we report the characterization of mouse
cPLA2g, an egg and embryo-abundant phospholipase A2g
that localizes mainly to the cortex and nucleoplasm of
oocytes and early cleavage division blastomeres. Given its
homology to phospholipase A2, we predict that mouse
cPLA2g may be involved in lipid metabolism and mem-
brane remodeling events during oogenesis and preimplanta-
tion development. Our finding that mouse cPLA2g
concentrates at the nuclear envelope during germinal vesicle
breakdown supports this prediction.Materials and methods
Identification of mouse cPLA2c peptide sequences by
tandem mass spectroscopy
Mouse oocyte proteins (2850) were collected and
separated on 16 cm 2D electrophoretic gels, as previously
described (Wright et al., 2003). A protein spot of
approximately 67.8 kDa (pI 5.7) was cored from a
Coomassie-stained gel, digested with trypsin, and micro-
sequenced by tandem mass spectrometry as previouslydescribed (Wright et al., 2003). The obtained peptide
sequence information was then compared against database
sequences using the NCBI Blast Website (http://www.
ncbi.nlm.nih.gov/BLAST/).
RACE-PCR cloning of mouse cPLA2c cDNA
The mouse cPLA2g open reading frame was amplified
from a mouse oocyte adapter-ligated cDNA library by
RT-PCR using DNA polymerase (Amplitaq Gold, Perkin-
Elmer, Norwalk, CT) as previously described (Wright et
al., 2003). Cycling parameters were: 94-C, 10 min;
94-C, 15 s; 60-C, 30 s; 72-C, 2 min for 40 cycles; and
72-C, 10 min. PCR of plasmid templates was performed
under the same conditions except that Taq polymerase
(Promega Advantage 2) was used. The primers for
cloning the full length ORF of the mouse PLA2g into
the TOPO cloning vector (Invitrogen) were 5V-ATG-
GAACTAAGCTCTGGGGTC-3V and 5V-AGGGTGTTG-
TATAGATTCCTA-3V, and the AP1 primer was supplied
within the Marathon ready cDNA kit (Clontech, Palo
Alto, CA).
Northern blot analysis
A randomly primed probe was generated corresponding
to the 900 bp N-terminal region of the mouse cPLA2g using
the Prime-a-Gene Labeling System (Promega, Madison,
WI). Northern blot analysis was performed as described
previously (Wright et al., 2003). Signals were detected by
exposure to X-ray film for 10 days.
Expression of recombinant protein and antibody production
Primers were designed to generate a PCR product
encoding amino acids 1–110 of the mouse cPLA2g open
reading frame. The sense gene-specific primer sequence
was 5V-ATGGAACTAAGCTCTGGGGTC-3V with the
three prime end containing an engineered BamHI restric-
tion site. The antisense gene specific primer sequence was
5V-TCCAGTCTAAAGAAGCAAGTG-3V and contained an
engineered XhoI restriction site. The primers were used to
amplify the cDNA fragment, and the PCR product was
cloned into the BamHI–XhoI restriction sites of the
pET22b expression vector (Novagen, Madison, WI). The
recombinant protein was then expressed and purified as
described previously (Wright et al., 2003). Preimmune
serum was collected from adult male guinea pigs, and
each animal was then injected with 100 Ag of purified
recombinant mouse cPLA2g in an emulsion with Freund’s
complete adjuvant. The animals received one booster
immunization with 50 Ag of the purified recombinant
mouse cPLA2g in Freund’s incomplete adjuvant at 3-
week intervals. The polyclonal sera was then collected
and prepared as previously described (Wright et al.,
2003).
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We performed 1 and 2D Western blot analysis to
confirm the specificity of the mouse cPLA2g antibody. For
1D analysis, BL21 cells expressing recombinant cPLA2g
were sonicated and 20 Ag of bacterial protein as well as
fifty oocytes were solubilized in Laemmli buffer (Laemmli,
1970) and heat denatured at 95-C. The samples were then
loaded onto a 12.5% linear gel and separated at 100 V for
3 h. Proteins were then electro-transferred onto 0.2 Am
nitrocellulose (Bio-Rad Laboratories, Hercules, CA) for 40
min at 100 V for Western blotting. For 2D Western blot
analysis, proteins from ¨800 zona-intact ovulated meta-
phase-II-arrested eggs were extracted, separated by 2D gel
electrophoresis (16  16 cm PAGE), and immunoblotted
as previously described (Wright et al., 2003). A 1:2000
dilution of the mouse cPLA2g preimmune and immune
antisera were used for the 1 and 2D Western blot
experiments.
For analysis of mouse cPLA2g protein expression during
oocyte maturation and preimplantation development, ger-
minal vesicle oocytes were obtained as described previously
(Coonrod et al., 1999, 2001). Metaphase II eggs (MII) were
isolated from the oviducts of superovulated female mice.
Pronuclear zygotes (PN), 2-cell, 4–8-cell, morula (Mo), and
blastocyst (Bl) embryos were isolated from the oviducts and
uterus of superovulated and mated female mice. Twenty
oocytes/embryos from each stage were boiled for 5 min in
Laemmli buffer and directly loaded into a 10% SDS-PAGE
gel. Proteins were separated at 200 V for 50 min and then
transferred to a nitrocellulose membrane by applying a
current of 90 V for 90 min. All blots were blocked with 5%
nonfat dry milk in TBS with 0.1% Tween-20 (TBS-T) for 30
min, washed, and incubated with a 1:5000 dilution of anti-
recombinant PLA2g guinea pig IgG. The blots were then
washed 3 times for 10 min in TBS-T and incubated with a
1:10,000 dilution of peroxidase-conjugated goat anti-guinea
pig IgG secondary antibody (Jackson ImmunoResearch,
West Grove, PA) for 1 h. Following incubation in secondary
antibody, the membranes were washed 3 times for 10 min in
TBS-T, and ECL reagent (Amersham Corp. Buckingham-
shire, UK) was applied for 2 min and developed as
previously described (Coonrod et al., 1999). The experi-
ments were repeated three times.
RT-PCR of mouse cPLA2c in oocytes and eggs
For analysis of RNA expression of mouse cPLA2g during
maturation and preimplantation development, germinal
vesicle oocytes were obtained as described previously
(Coonrod et al., 1999, 2001). Metaphase II eggs (MII) were
isolated from the oviducts of superovulated female mice.
Pronuclear zygotes (PN), 2-cell, 4–8-cell, morula (Mo), and
blastocyst (Bl) embryos were isolated from the oviducts and
uterus of superovulated and mated female mice. Total RNA
from 20 oocyte/embryos at each stage was extracted using200 Al of TRIzol reagent as described in manufacturer’s
protocol. RT-PCR was performed using a one-step RT-PCR
kit (Sigma Pro HSRT-100) under the following experimental
conditions: 2 Al of total RNA from each stage was added to 25
Al reactions containing 10 mM Tris–HCl, pH 8.3, 50 mM
KCl, 1.5 mMMgCl2, 0.001% gelatin, 200 AM dNTPs, 0.4U/
Al RNase inhibitor, 0.4 AM of each primer, 0.4U/Al Avian
Reverse Transcriptase, and 0.05U/Al JumpStart AccuTaq LA
DNA polymerase. The following mouse cPLA2g ortholog
primers were used: 5V-GGTAAGGACTGCTGACA-
GTGGCTAGCT-3V; 5V-CCTCCAGAAGTGTCAAGCTGG-
TAGATGT-3V. Thermocycler settings consisted of 30 min at
50-C, 2 min at 95-C, and 34 cycles at 95-C (15 s), 52-C
(30 s), and 72-C (1 min) followed by 10 min at 72-C. Twenty
percent of product was later analyzed on a 1.4% agarose gel.
The experiments were repeated three independent times.
Immunohistochemistry of ovarian sections
Adult female mouse ovaries were fixed in 4% parafor-
maldehyde, embedded in paraffin wax, cut in 5 Am sections,
and processed for immunohistochemistry. In brief, the
paraffin wax was removed using Neo Clear Clarificationi
(EM Science, NJ, USA), and the section was rehydrated
through a graded series of ethanol solutions (100–70%) in
H2O. To localize the mouse cPLA2g in the histological
sections, endogenous peroxidase activity was first removed
by treatment with 3% H2O2 for 20 min at room temperature.
After washing with PBS-BSA (0.15%), slides were blocked
for 20 min with BSA (2%) and then incubated overnight with
the mouse cPLA2g guinea pig preimmune or immune
antisera (1:500 in PBS-BSA 0.15%). Next, the slides were
washed and incubated with biotinylated secondary antibody
for 30 min, washed again, and treated with VECTASTAIN
elite ABC reagent (Vector Laboratories, Burlingame, CA)
for 30 min. Finally, the sections were incubated with a
peroxidase substrate solution until the desired staining levels
were obtained, rinsed in tap water, counterstained with
hematoxylin, cleared with Neo Clear Clarificationi,
mounted on slides using mounting media (Permount, Fisher
Chemicals), and visualized at 100.
Indirect immunofluorescence of oocytes and embryos
All oocytes and embryos were obtained from ICR 25–30
g females. Germinal vesicle oocytes were obtained as
described previously (Coonrod et al., 1999, 2001). Meta-
phase II eggs (MII) were isolated from the oviducts of
superovulated female mice. Pronuclear zygotes (PN), 2-cell,
4–8-cell, morula (Mo), and blastocyst (Bl) embryos were
isolated from the oviducts and uterus of superovulated and
mated female mice and immediately fixed in 4% parafor-
maldehyde in PBS for 30 min at room temperature.
Following fixation, oocytes and embryos were washed 5
times in IF media (PBS + 1% BSA + 0.5 NGS) and then
permeabilized with 0.5% Triton-X 100 in PBS for 30 min.
Fig. 1. Location of mouse cPLA2g (67.8 kDa, pI 5.7) on a Coomassie-
stained two-dimensional electrophoretic gel of 2850 extracted mouse oocyte
proteins. The arrow indicates a spot that was cored from the gel for tandem
mass spectroscopic identification of the mouse cPLA2g peptides. Two other
protein spots of higher acidity (to the left of the arrow and contained within
brackets) were later shown to be reactive with the mouse cPLA2g immune
sera, possibly indicating post-translationally modified isoforms.
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incubated with the mouse cPLA2g guinea pig preimmune
and immune antisera 1:300 in IF media for 1 h at room
temperature. Oocytes and embryos were washed 5 times and
incubated for 3 h at room temperature with goat anti-guinea
pig FITC-labeled secondary antibody (Jackson Immuno-
research). Experiments were repeated at least three times,
using 20 to 30 oocytes/embryo per developmental stage,
pooled from 3 mice.
To evaluate GVBD, geminal vesicle oocytes were
collected and either immediately fixed in 4% paraformalde-
hyde in PBS (time 0) or incubated at 37-C and 5% CO2 in
maturation buffer (TYH buffer) as previously described
(Wright et al., 2003). The oocytes were then fixed at 40, 60,
90, 120 min, and 24 h, permeabilized, and washed as
described above. The oocytes where then incubated with the
mouse cPLA2g guinea pig preimmune and immune antisera
1:300 in IF media for 1 h at room temperature followed by
an incubation with a 1:1000 dilution of anti-lamin A/C IgG
(Santa Cruz, CA) or with a 1:2000 dilution of anti-g-tubulin
(Sigma, MO) at 4-C overnight. The oocytes were washed 5
times and incubated for 3 h at room temperature with goat
anti-guinea pig FITC-labeled secondary antibody (Jackson
Immunoresearch) together with goat anti-rabbit Texas Red-
labeled secondary antibody (Jackson Immunoresearch) to
recognize lamin A/C or g-tubulin and Hoechst to stain the
DNA. Finally, oocytes/embryos were mounted on slides and
visualized at 1000 under a Zeiss Axiovert-200 deconvo-
lution fluorescence microscope and imaged. Experiments
were repeated at least three times, using 30 to 40 oocytes per
time point which were pooled from 4 to 6 mice.Results
Tandem mass spectroscopic identification of mouse cPLA2c
Protein extract from 2850 zona-free mouse eggs was
separated by two-dimensional electrophoresis and stained
with Coomassie (Fig. 1). One protein spot, later designated
as mouse cPLA2g (Fig. 1, arrow), with a molecular weight
of 67.8 kDa and isoelectric point of 5.7, was cored from the
gel, digested with trypsin, and microsequenced by CAD
mass spectrometry. This analysis revealed 21 unique
peptides that did not match previously characterized protein
sequences in the nonredundant database. We therefore
concluded that this protein was novel. However, one peptide
with the sequence FIEGPVTYSEAPR did match an EST
clone, C88186, from a fertilized egg cDNA library.
Cloning and characterization of mouse cPLA2c
Oligonucleotide primers (designed from either the
FIEGPVTYSEAPR peptide sequence or from the matching
EST sequences) were used for repeated RACE-PCR
reactions to amplify a 2701 bp cDNA from the ovariancDNA library which contained the mouse cPLA2g open
reading frame. The cPLA2g cDNA (GenBank accession
number AY694793) was inserted into a cloning vector, and
subsequent sequence analysis revealed a 75 bp 5V untrans-
lated region, a contiguous open reading frame of 1791 bp
(encoding a deduced protein of 597 amino acids), and a 796
bp 3V untranslated region (Fig. 2). The untranslated flanking
regions are shown in lower case letters in Fig. 2. The
computed mass and isoelectric point (ExPASy compute pi/
MW algorithm) of the deduced amino acid sequence are 66
kDa and 5.36 pI, respectively, which closely match the mass
and pI of the protein spot that was cored from the 2D gel for
TMS analysis. Thirteen of the 21 peptides originally
identified by TMS were found in the deduced amino acid
sequence and are underlined in Fig. 2. Comparing deduced
amino acid sequence against the database sequence using
the NCBI conserved domain function (www.ncbi.nlm.nih.
gov/Structure/cdd/wrpsb.cgi) resulted in significant similar-
ities with both a cytoplasmic phospholipase A2 (PLA2)
domain (E value = 2e  31) and a PLA2 B lysophospho-
lipase catalytic domain (E value = 3e  51). The first
domain is found in enzymes that hydrolyze arachidonyl
phospholipids and overlaps the ¨300 aa N-terminus of the
mouse cPLA2g. The latter, observed between residues 45
and 503, is found in enzymes that catalyze the release of
fatty acids from lysophospholipids.
Comparison of the sequence against the NCBI non-
redundant database using the BLASTp algorithm found
100% identity with a deduced protein sequence (XP
149881.2) named phospholipase A2 gamma, group IVC
(cytosolic calcium-independent). The sequence is ¨80%
Fig. 2. Complementary DNA sequence and deduced amino acid sequence
of mouse cPLA2g. The untranslated flanking regions are shown in lower
case letters. Peptide sequences originally obtained by mass spectrometry are
underlined.
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identical to previously characterized human cPLA2g, and
¨27% identical to chicken cPLA2a. A Blast analysis of the
mouse cPLA2g nucleotide sequence against the mousegenome reveals that mouse cPLA2g is located on mouse
chromosome 7 and is flanked by two genes, SLC27A5 and
APOC1, which are also associated with lipid metabolism.
Analysis of human cPLA2g finds that this gene is located on
chromosome 19 at position q13.3. This position also contains
the human orthologs of mouse SLC27A5 and APOC1, thus
suggesting that mouse and human cPLA2g are, in fact,
orthologous. A further comparison of the mouse cPLA2g
sequence with human cPLA2g shows that both molecules
lack the cPLA2a calcium-dependent lipid binding domain
yet retain the residues which comprise the cPLA2a catalytic
triad (Fig. 3, arrowheads). However, as opposed to human
cPLA2g, mouse cPLA2g lacks obvious N-terminal myris-
toylation (M-G-X-X-X(S/small uncharged)-X) and C-termi-
nal prenylation (-CCLA) membrane anchoring motifs (Fig. 3,
boxes), indicating that perhaps mouse cPLA2g is not
membrane anchored.
Mouse cPLA2c expression is limited to the ovary
An EST database search using the mouse cPLA2g ORF
nucleotide sequence found multiple identical or near
identical matches with ovary, unfertilized egg, fertilized
egg, 2-cell, and 4–8-cell cDNAs. Single matches were also
obtained with cDNA clones derived from adult male colon
(GenBank accession no. BB624941) and infiltrating ductal
carcinoma (GenBank accession no. BX524494) somatic
tissues. This information led to the prediction that mouse
cPLA2g may either be an egg-abundant or egg-specific
transcript whose expression persists throughout the early
stages of cleavage. Mouse cPLA2g expression was then
examined in various tissues using Northern blot analysis
(Fig. 4). Two blots, one containing 5 Ag multi-tissue poly-
A+ RNA, and the other, 40 Ag of total ovarian RNA, were
probed with a 32P-labeled random-primed 900 bp mouse
cPLA2g N-terminal DNA fragment. The probe, while not
binding to RNA from somatic and testicular RNA, did
recognize a ¨2.7 kb ovarian transcript (Fig. 4). Subsequent
multiple tissue Northern blotting experiments using a single
membrane showed similar results (data not shown).
A 67.8 kDa (pI 5.7) protein spot which contains mouse
cPLA2c peptide sequence is specifically recognized by
anti-mouse cPLA2c antibodies
cDNA encoding an N-terminal ¨110 amino acid region
of mouse cPLA2g was cloned into a bacterial expression
vector, expressed, purified, and used as an immunogen for
mouse cPLA2g antisera production in guinea pigs. Anti-
body specificity was first confirmed by 1D Western blotting
(data not shown) which found that the mouse cPLA2g
antisera was reactive with recombinant cPLA2g and with an
appropriately sized egg protein. On 2D immunoblots, the
anti-mouse cPLA2g sera reacted with a ¨67.8 kDa protein
(pI 5.7), which is the precise location of the protein spot that
was originally cored from the Coomassie-stained gel of
Fig. 3. Amino acid sequence comparison of mouse cPLA2g with human cPLA2g. The sequences were aligned using the ClustalW alignment program in
BioEdit sequence alignment editor. Identical residues are shown in dark gray boxes, and conserved residues are shown in light gray boxes. Dashes indicate gaps
inserted to maximize sequence alignment. As opposed to human cPLA2g, mouse cPLA2g lacks obvious N-terminal myristoylation and C-terminal prenylation
membrane anchoring motifs (boxes). Catalytic triad is shown with arrowheads.
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arrow). The preimmune sera was not reactive with egg
proteins (Fig. 5). These results provided immunological
proof that specific antibodies had been generated against the
original cored protein. Interestingly, the mouse cPLA2g
immune sera was also reactive with two other slightly more
acidic protein spots of similar molecular weight (asterisk in
Figs. 1 and 5), indicating that mouse cPLA2g may be post-
translationally modified.Fig. 4. Mouse cPLA2g tissue distribution. Northern blot analysis was
performed on various tissues using a P32-labeled 900 bp mouse cPLA2g
DNA fragment. Mouse cPLA2g was detected as a single ¨2.7 kilobase
band in the ovarian RNA lane. A h-actin probe was used to control for
RNA loading. Tissues included ovary, heart, brain, spleen, lung, liver,
skeletal muscle (SM), kidney, and testis.Developmental expression and subcellular localization of
mouse cPLA2c
Immunohistochemical localization of mouse cPLA2g in
adult ovaries showed that the protein localized mainly to
oocytes in preantral and antral stage follicles, as indicated
by the strong brown staining (Fig. 6). Weak staining of
surrounding stromal tissue was also observed. While the
preimmune sera was not reactive with oocytes, it was
weakly reactive with stromal tissue indicating that the
staining of the stromal cells with the immune sera was likely
non-specific (Fig. 6, inset). No detectable staining was seen
in adjacent sections when the primary antibody was omitted
(data not shown).
We next investigated the expression and subcellular
localization of mouse cPLA2g protein during oocyte
maturation, fertilization, and early embryonic development.
Immature germinal vesicle stage oocytes (GV), mature
metaphase-II-arrested eggs (MII), pronuclear zygotes (PN),
2-cells, 4–8-cells, morulas (Mo), and blastocysts (Bl) were
collected in vivo and immediately frozen for RT-PCR and
Western blot analysis or fixed for immunofluorescence
staining.
RT-PCR analysis showed that mouse cPLA2gmRNAwas
expressed in GV oocytes, MII, and PN zygotes but was not
expressed in 2-cell embryos, 4–8-cell embryos, Mo, or Bl
(Fig. 7A). Western blot analysis showed that mouse cPLA2g
was expressed in GV stage oocytes and that a strong level of
expression persists through the MII, PN, 2-cell, and 4–8-cell
stages (Fig. 7B). By the morula stage, however, mouse
cPLA2g levels decrease dramatically and remain low
Fig. 5. Two-dimensional Western blot analysis demonstrating that mouse cPLA2g immune sera is reactive with the 67.8 kDa (pI 5.7) mouse cPLA2g protein
spot. Mouse cPLA2g preimmune sera was not reactive with egg proteins. However, mouse cPLA2g immune sera strongly reacts with the protein spot which
contained the mouse PLA2g peptides. An arrow indicates the spot which was originally cored for TMS analysis. Note that two other slightly more acidic
proteins are reactive with the immune sera (asterisks), possibly indicating that mouse cPLA2g is post-translationally modified. Overlay image localizes reactive
proteins with protein spots resolved using protogold.
Fig. 6. Mouse cPLA2g localization in ovary. Ovarian cross-sections from
mature females were probed with anti-mouse cPLA2g sera or preimmune
sera (inset) and visualized using immunoperoxidase staining. Mouse
cPLA2g expression was observed in oocytes (arrows) contained within
preantral (PF) and antral follicles (AF). 100. PI: preimmune sera.
Fig. 7. Developmental expression of mouse cPLA2g in oocytes and
embryos. Germinal vesicle (GV), metaphase II (MII), pronuclear (PN), 2-
cell, 4–8-cell, morula (Mo), and blastocyst (Bl) were collected from
hormonally stimulated mice, and RNA was extracted for RT-PCR (A) or
protein was extracted for Western blot analysis (B). (A) Specific primers
based on the mouse cPLA2g open reading frame were used in PCR
reactions. RNA transcripts could be visualized in GV staged oocytes, MII
eggs, and PN staged embryos. (B) Western blots of oocyte/embryo extracts
were probed with immune IgG. cPLA2g protein expression appeared
highest in GV staged oocytes through 4–8-cell staged embryos and then
declined at Mo and Bl stages of development. Prior to immunostaining, the
blots were probed with Ponceau to control for protein loading.
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Fig. 8. Subcellular localization of cPLA2g in oocytes and preimplantation
embryos. Germinal vesicle (GV) oocytes were obtained from ovaries of
female mice. Metaphase II eggs (MII) were isolated from the oviducts of
superovulated female mice. Pronuclear zygotes (PN), 2-cell, 4–8-cell,
morula (Mo), and blastocyst (Bl) embryos were isolated from the oviducts
and uterus of superovulated and mated female mice. All oocyte/embryos
were fixed immediately after collection. Mouse cPLA2g protein was
expressed in immature GV stage oocytes (B), PN (C), 2-cell (D), and 4–8-
cell embryos (E). At the subcellular level, mouse cPLA2g mainly localized
to the cortical region and the nucleoplasm. Protein levels were diminished
in Mo and Bl staged embryos (F and G). The preimmune serum was not
reactive with GV oocytes (A) or embryos (data not shown). IF—indirect
immunofluorescence, Ph—phase contrast, 1000.
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localization of mouse cPLA2g in oocytes and early embryos,
immunofluorescent (IF) analyses were conducted using
deconvolution microscopy. In support of our Western blot
analysis, IF also showed that mouse cPLA2g was expressed
predominantly in GV staged oocytes (Fig. 8B), zygotes (Fig.
8C) and during early embryonic cleavage divisions (Figs. 8D
and E), with decreased staining observed in morula and
blastocysts (Figs. 8F and G). At the subcellular level, mouse
cPLA2g appears to mainly localize to the cortical region and
nucleoplasm of oocytes and early stage blastomeres.
Interestingly, in 2-cell and 4–8-cell embryos (Figs. 8E and
F), blastomere cortical staining is mainly limited to regions
that are in contact with the extracellular space. Preimmune
serum was not reactive with GV stage oocytes (Fig. 8A),
eggs, or preimplantation stage embryos. In addition, eggs
stained with immune sera that had been preabsorbed with
recombinant mouse PLA2g lacked both nuclear and cortical
staining, indicating that the immune sera is specific for
mouse cPLA2g and was generated against the original cored
protein (Supplementary Fig. 3).
Dynamic targeting of mouse cPLA2c aggregates to the
nuclear envelope during germinal vesicle breakdown
While investigating mouse cPLA2g localization in GV
oocytes, we noticed that the protein sometimes appeared to
concentrate in aggregates either in the oocyte cortex or
around the nuclear envelope. We predicted that the different
localization patterns may be due to targeting of the cPLA2g
aggregates to the nuclear envelope during spontaneous
germinal vesicle breakdown (GVBD). In order to test this
hypothesis, we released pools of germinal vesicle stage
oocytes from ovarian follicles, fixed the cultured oocytes at
different time points, and stained them with mouse cPLA2g
sera. Results showed that, at 0 to 40 min following the onset
of spontaneous maturation, mouse cPLA2g aggregates were
concentrated at two foci located near the oocyte cortex (Fig.
9B, arrows). At later time points (40 to 60 min), more
abundant foci were then seen surrounding the nucleus, while
the cortical cPLA2g foci were not observed (Fig. 9E,
arrow). A search of the literature found that a unique g-
tubulin-positive egg-restricted structure termed multivesic-
ular aggregates (MVA) (Calarco, 2000) has a localization
pattern which was strikingly similar to that of the mouse
cPLA2g aggregates. To investigate if cPLA2g might
represent a component of the MVA complex, we then
repeated the GVBD experiment and co-stained the oocytes
with mouse cPLA2g (shown in green) and g-tubulin (red
staining, Fig. 9, upper panel). Results showed a strong co-
localization of cPLA2g and g-tubulin at the two cortical foci
(time = 0) and at the nuclear aggregates (time = 40–60 min)
(yellow staining, Figs. 9C and F, arrow). Our finding that
mouse cPLA2g appeared to aggregate at the germinal
vesicle ¨40–60 min after the initiation of spontaneous
maturation (when the nuclear envelope is known to begin to
Fig. 9. Dynamic relocalization of mouse cPLA2g aggregates from the oocyte cortex to the nuclear envelope during germinal vesicle breakdown. Oocytes were
fixed at different time points (0, 40, 60, 90, 120 min, and 24 h) and co-stained with mouse cPLA2g immune sera (B, E, H, K, N, and Q) and either anti-g-
tubulin (C and F) or anti-lamin A/C (I, L, O, and R). For these images, mouse cPLA2g is shown in green, and g-tubulin and lamin A/C are shown in red.
Yellow staining indicates co-localization of cPLA2g with either g-tubulin or lamin A/C. In GVoocytes fixed at time 0, two prominent cPLA2g aggregates were
observed near the cortex (B, arrows). These aggregates also co-localized with g-tubulin (C, arrow). At 40–60 min, the cPLA2g aggregates surrounded the
nuclear envelope (E, arrow) and co-localized with g-tubulin (F, arrow) but not lamin A/C (I, arrow). Between 60 to 90 min of culture, mouse cPLA2g
concentrates at regions of the nuclear envelope which appeared ruffled and stain positive for lamin A/C (K and L, arrows). At 90–120 min culture, mouse
cPLA2g aggregates were still found to surround lamin A/C and the condensed chromatin (N and O, arrow). At MII stage, mouse cPLA2g aggregates were
found in the cytoplasm and concentrated at the spindle poles (Q and R). IF—immunofluorescence, Ph—phase contrast, 1000.
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involved in this process. Therefore, we decided to perform
more cPLA2g co-localization experiments using anti-lamin
A/C antibodies (Ellenberg, 2002) in order to follow the
association of cPLA2g with the nuclear envelope during
GVBD (Figs. 9I, L, O, and R, shown in red). Results
showed that, at 40 to 60 min, the mouse cPLA2g aggregates
were found in accumulations surrounding the nuclear
envelope (as noted above in Figs. 9H and I, white arrow).
However, between 60 to 90 min, when the nuclear envelope
takes on a more ruffled appearance (red staining, Fig. 9L,
arrow), the mouse cPLA2g aggregates partially co-localize
with lamin A/C suggesting a more intimate association with
the nuclear membrane (Fig. 9L, arrow). Over the next 90
min, as the nucleus continued to undergo dissolution, the
mouse cPLA2g aggregates remained in the cytoplasm
closely apposed to lamin but were not seen to co-localize
with lamin (Fig. 9O, arrow). In metaphase-II-arrested eggs,
the mouse cPLA2g aggregates were found to be distributed
throughout the cytoplasm (Fig. 9Q, gray arrow). Interest-
ingly, positive staining was also observed at the poles of
metaphase spindle (Figs. 9Q and R, arrows), perhaps
suggesting a role for mouse cPLA2g in centrosomal
function. When the nuclear envelope reformed at the
pronuclear stage, strong cortical and homogeneous nuclear
staining returned and persisted until the morula stage of
development, while the mouse cPLA2g aggregates were no
longer observed (Fig. 8C).Discussion
In an effort to shed light on the molecular underpinnings
of the mammalian oocyte, this report documents the
characterization of a highly abundant novel egg and
embryo-restricted maternal protein which we have named
mouse cPLA2g. As a group, the heterogeneous PLA2
enzymes can be classified according to localization,
sequence homology, and biochemical characteristics. Fur-
thermore, they possess a diverse array of functions,
including acylation regulation (Jackowski, 1996), mem-
brane remodeling (Balsinde et al., 1997), cell proliferation
(Roshak et al., 2000), and transcriptional regulation (Tashiro
et al., 2004). The cytosolic (cPLA2) family consists of three
isozymes, cPLAa (IVA), cPLAh (IVB), and the poorly
characterized cPLAg (IVC) (Kudo and Murakami, 2002).
Several characteristics of cPLA2a include the protein
sequence GLSGS, which is critical for cPLA2a activity, a
catalytic triad (serine 82, aspartate 385, arginine 54), and a
regulatory calcium-dependent CaLB lipid binding domain.
Underwood et al. (1998) originally cloned human cPLA2g
and found that this novel family member contained a similar
lipase consensus sequence (i.e. GVSGS) as well as the
catalytic triad residues. However, human cPLA2g lacks the
CaLB domain of cPLA2a, suggesting that human cPLA2g
may not require calcium for activity (Asai et al., 2003). Theinvestigators then utilized recombinant human cPLA2g to
show that the protein preferentially catalyzes the hydrolysis
of arachidonic acid at the sn-2 position of membrane
phospholipids and is associated with cell membranes, likely
via its myristoylation and prenylation motifs. Like human
cPLA2g, mouse cPLA2g contains the lipase consensus
sequence (GVSGS), the catalytic triad, and lacks the CaLB
lipid binding domain. However, there are important differ-
ences between human and mouse cPLA2g. Unlike human
cPLA2g, mouse cPLA2g lacks a prenylation signaling motif
at its C-terminus (-CCLA) and a myristoylation signal
sequence at its N-terminus [(MGXXX(S/small uncharged)-
X]. These findings suggest that perhaps mouse cPLA2g is
not membrane anchored. This prediction is supported by our
immunofluorescence analysis showing that a portion of the
mouse cPLA2g appears to be distributed throughout both
the cytoplasm and nucleoplasm. In several other cell types,
PLA2s have been shown to translocate to either the nuclear
envelope or nuclear fraction upon stimulation with calcium
ionophore (Irvine, 2003), and therefore our findings that
mouse cPLA2g partially localizes to the nucleus are not
without precedent. Another important difference between
human and mouse cPLA2g is that human cPLA2g is mainly
limited to the heart and skeletal muscle, while mouse
cPLA2g expression appears to be restricted to the oocyte
and early embryo. This finding, coupled with the observa-
tion that mouse cPLA2g partially localizes to the nucleus
and does not appear to be membrane anchored, suggests that
human and mouse cPLA2g may have different biological
functions.
With respect to the potential function of mouse cPLA2g,
our immunofluorescence analysis shows that, when oocytes
are isolated from follicles and fixed immediately, two large
concentrated mouse cPLA2g foci are observed near the
oocyte cortex. Following ¨40 to 90 min of culture,
however, the mouse cPLA2g foci are clustered around the
nuclear envelope. This result suggests that the two cPLA2g
foci migrate from the oocyte cortex towards the nuclear
envelope during GVBD where they then fragment into
smaller aggregates which surround the nucleus. We were
struck by this finding and searched the literature to
investigate if other molecules or structures showed similar
dynamics during GVBD. Surprisingly, this staining pattern
was highly reminiscent to that of a novel oocyte structure
termed multivesicular aggregates (MVA). These large (¨10
Am) g-tubulin-positive structures contain a variety of
vesicular structures and are initially observed as two foci
near the oocyte cortex but then break up into smaller
fragments and surround the nuclear envelope during oocyte
maturation. Some of these MVAs are then thought to
eventually transform into the microtubule organizing centers
(MTOC) following GVBD (Calarco, 2000; Palacios et al.,
1993). Our finding that there is a precise co-localization of
g-tubulin and cPLA2g aggregates during GVBD strongly
supports the hypothesis that cPLA2g represents a compo-
nent of the novel MVA structure. Furthermore, the local-
A. Vitale et al. / Developmental Biology 282 (2005) 374–384384ization of cPLA2g to the spindle poles in metaphase II-
arrested eggs suggests that cPLA2g may also represent a
component of the MTOC.
A signature feature of spontaneous GVBD is the nuclear
envelop ruffling that occurs prior to membrane dissolution
within a few hours of culture in vitro (Wassarman and
Albertini, 1994). Although the mechanism by which GVBD
occurs is unknown, in mitotic cells, nuclear envelope
dissolution and reformation are known to be catalyzed by
multiple enzymes, including phospholipases. We found that
mouse cPLA2g often appeared to concentrate at the ruffled
regions of the nuclear envelope during germinal vesicle
breakdown (as determined by the co-localization of mouse
cPLA2g and lamin shown in Fig. 9L) suggesting that this
maternal protein may play a role in nuclear envelope
dissolution during GVBD.
To conclude, mouse cPLA2g represents one of the
more abundant proteins in the egg proteome. Northern blot
and immunohistochemical analyses find that mouse
cPLA2g expression is limited to the oocyte and early
embryo. In the oocyte, mouse cPLA2g undergoes a
striking migration from the oocyte cortex to the nuclear
envelope during GVBD, suggesting a possible role in
nuclear membrane remodeling. Furthermore, we show by
Western blot and indirect immunofluorescence analysis
that mouse cPLA2g protein continues to be expressed in
embryos until the 4–8-cell stage of development suggest-
ing a possible role for this maternal protein in early
embryonic development. Therefore, we believe further
consideration of the function of this novel phospholipase
A2-like protein is warranted.Acknowledgment
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